Old Web
English
Sign In
Acemap
>
authorDetail
>
Alyson K Freeman
Alyson K Freeman
Novartis
Cancer research
Melanoma
MAPK/ERK pathway
Biology
Mutant
3
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
RAF-mutant melanomas differentially depend on ERK2 over ERK1 to support aberrant MAPK pathway activation and cell proliferation.
2021
Molecular Cancer Research
Matthew S. Crowe
Tatiana Zavorotinskaya
Charles F. Voliva
Matthew D. Shirley
Yanqun Wang
David A. Ruddy
Daniel P. Rakiec
Jeffrey A. Engelman
Darrin Stuart
Alyson K Freeman
Show All
Source
Cite
Save
Citations (0)
Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma
2019
Molecular Cancer Research
Grace P. Leung
Tianshu Feng
Frederic D. Sigoillot
Felipe Correa Geyer
Matthew D. Shirley
David A. Ruddy
Daniel Rakiec
Alyson K Freeman
Jeffrey A. Engelman
Mariela Jaskelioff
Darrin Stuart
Show All
Source
Cite
Save
Citations (23)
BRAF-inhibitor associated MEK Mutations Increase RAF-dependent and-independent Enzymatic Activity
2017
Molecular Cancer Research
Caroline Emery
Kelli-Ann Monaco
Ping Wang
Marissa Balak
Alyson K Freeman
Jodi Meltzer
Scott Delach
Daniel Rakiec
David A. Ruddy
Joshua M. Korn
Jacob R. Haling
Michael G. Acker
Giordano Caponigro
Show All
Source
Cite
Save
Citations (8)
1